Delivery Order SPE2DB22D1017-SPE2DB24FF5LH
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,956,809 units of Abiraterone Acetate 250 mg tablets. The $1,742.07 award has a performance period through March 14, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,473,055 units of Abiraterone Acetate 250 mg tablets. The $1,208.60 contract has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the company's larger indefinite delivery contract with DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply a pharmaceutical product - 4563970021 ABIRATERONE ACETATE 500 MG TAB 60S. The contract has a ceiling value of $4,146.27 and a period of performance through March 15, 2024. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Abiraterone Acetate 250 mg tablets. The contract, valued at $33,613.26, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price agreement with a performance period through July 16, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation,...
- This contract award, with ID SPE2DB22D3501|SPE2DB25FTG77, is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,667.28 firm-fixed-price contract is for the delivery of 4,566,216,846 units of abiraterone acetate 250 mg tablets by October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $25,329.84 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) under a firm fixed-price contract. The delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This contract was competitively awarded without set-aside designation, reflecting open competition among...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Abiraterone Acetate 500mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,920.00 and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
- The Defense Logistics Agency awarded a delivery order valued at $96,898.94 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,143.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, with a completion date of February 14, 2024. Amerisourcebergen Drug Corp serves as the prime contractor under this delivery order, which is part of a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,504.96 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of ABRYSVO VIAL WITH DILUENTS, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
Teaming
Find teaming partners for this award
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5LHDelivery Order
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,667.28 firm fixed price delivery order contract (SPE2DB22D1017|SPE2DB24FF5LH) to provide 4,564,184,345 units of Abiraterone Acetate 250 mg tablets. This delivery order is under an indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside designation and the period of performance runs through April 8, 2024.
Generated 7/5/24, 9:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/5/24 |